Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
₹10 L
EMD Value
₹10,000
Closing Date
2 Nov 2026, 12:00 pm
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
DEAN, Rajiv Gandhi Govt General Hospital, chennai
Rajiv Gandhi Govt General Hospital, chennai
Tender for medicines
2026_DMER_714232_1
024461/MS3/2026
Open Tender
Medicines
Supply
Rajiv Gandhi Govt General Hospital
Please refer Tender documents.
8 documents required · 8 mandatory
₹0
₹10,000
Yes
16 Oct 2026
16 Oct 2026
3 Nov 2026
16 Oct 2026
2 Nov 2026
16 Oct 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount | GST % |
|---|---|---|---|---|---|---|
| 0.1 | Name of Medicines | - | - | - | - | - |
| 1 | T. Amiodarone 100 mg | 1 | No | 65 | ₹65 | 5% |
| 2 | T. Carvedilol 6.25 mg | 1 | No | 65 | ₹65 | 5% |
| 3 | T. Rivaroxaban 10 mg | 1 | No | 65 | ₹65 | 5% |
| 4 | T. Trimetazidine 35 mg | 1 | No | 65 | ₹65 | 5% |
| 5 | T. Folinic Acid 25 mg | 1 | No | 65 | ₹65 | 5% |
| 6 | Inj. Thiamine 100 mg | 1 | No | 65 | ₹65 | 5% |
| 7 | Inj. Bupivacaine 0.5% heavy spinal ampoule | 1 | No | 65 | ₹65 | 5% |
| 8 | Inj. Irinotecan 100 mg | 1 | No | 65 | ₹65 | 5% |
| 9 | Inj. Irinotecan 40 mg | 1 | No | 65 | ₹65 | 5% |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.38 MB
BOQ_858018.xls
BOQ • 0.37 MB
tenderdocumenthq.pdf
Tender Documents • 1.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .